Skip to main content
MedVellum
QuestionsVideosPricing

MedVellum

Fellowship exam preparation across every specialty: source-verified topics, questions in every format, and videos.

Product

  • Specialties
  • Questions
  • Videos
  • Exam tools
  • Pricing

Verification & policy

  • Verified register
  • Editorial policy
  • Privacy
  • Terms

Account

  • Sign in
  • Create account
  • Dashboard
  • Account & billing

© 2026 MedVellum. For education only — not a substitute for clinical judgement.

llms.txtPsychiatry LLM catalogSitemap

GP Vivasdermatological-presentations

GP Vivas · dermatological-presentations

Atopic eczema — structured viva

Structured oral on atopic eczema: defending generous steroids against steroid phobia with Cochrane safety numbers, fingertip-unit dosing, calcineurin inhibitor placement, bleach-bath honesty, dupilumab escalation and the sleep-psychological burden argument.

structured clinical oral2 min readVerification in progress

Target exams

RACGP CCEFRACGP oralsMRCGP SCA
On this page
Study tools

Target exams

RACGP CCEFRACGP oralsMRCGP SCA
Prompt
The examiner opens: 'A colleague tells parents to avoid steroids because they thin children's skin — dismantle that, then tell me what you would do for severe disease.' The viva branches through safety numbers, dosing mechanics, infection emergencies, biologics and burden.

Stem

You are the GP. A parent says: "I never use the steroid cream you gave — it thins her skin." Her daughter's eczema has been flaring nightly for three months. [8]

General Practice Pro

Continue reading

You have read the opening of this viva. The complete unit — every section and its primary-source references — is part of the General Practice fellowship library.

Sign in to continueSee pricing
References8ShowHide
  1. [1]Long CC et al. The finger-tip unit--a new practical measure. Clinical and experimental dermatology, 1991.PMID 1806320
  2. [2]Simpson EL et al. Two Phase 3 Trials of Dupilumab versus Placebo in Atopic Dermatitis. The New England journal of medicine, 2016.PMID 27690741
  3. [3]Blauvelt A et al. Long-term management of moderate-to-severe atopic dermatitis with dupilumab and concomitant topical corticosteroids (LIBERTY AD CHRONOS). The Lancet, 2017.PMID 28478972
  4. [4]George SM et al. Interventions to reduce Staphylococcus aureus in the management of eczema. The Cochrane database of systematic reviews, 2019.PMID 31684694
  5. [5]Stacey SK et al. Topical Corticosteroids: Choice and Application. American family physician, 2021.PMID 33719380
  6. [6]Axon E et al. Safety of topical corticosteroids in atopic eczema: an umbrella review. The British journal of dermatology, 2021.PMID 34233978
  7. [7]Bakaa L et al. Bleach baths for atopic dermatitis: A systematic review and meta-analysis including unpublished data, Bayesian interpretation, and GRADE. Journal of the American Academy of Dermatology, 2022.PMID 35367346
  8. [8]Lax SJ et al. Topical Anti-Inflammatory Treatments for Eczema: A Cochrane Systematic Review and Network Meta-Analysis. JAMA dermatology, 2024.PMID 39219446
General Practice Pro

$29/ monthor $279 / year

The complete General Practice library, every exam format, one subscription.

  • Complete library for one chosen specialty
  • Timed MCQ mock exams and spaced review
  • Clinical cases & cross-table vivas
See pricingSign in
PreviousAntimicrobial stewardship in general practice — structured vivainfectious-diseasesNextMelanoma and keratinocyte skin cancer detection — structured vivadermatological-presentations